Maha Abid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maha Abid has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Amel Letaief
Infectious Diseases Department, Farhat Hached University Hospital, Ibn El Jazzar Medical School, University of Sousse, Sousse, Tunisia
2 shared publications - Dorsaf Slama
Farhat Hached Univ Hosp, Dept Infect Dis, Sousse 4000, Tunisia
1 shared publication - Foued Bellazreg
Faculty of Medicine, University of Sousse, Sousse, Tunisia
1 shared publication - Houneida Zaghouani
Farhat Hached Univ Hosp, Dept Radiol, Sousse 4000, Tunisia
1 shared publication - Nadia Ben Lasfar
Infectious Diseases Department, Farhat Hached University Hospital, Sousse 4000, Tunisia
1 shared publication - Sana Rouis
Infectious Diseases Department
1 shared publication
Latest Publications
- Open Access
- 11 October 2023
- Published by IntechOpen
Recurrent Cystitis in Women: Optimal Recommended Diagnostic Evaluation, Management and Prevention Options
Cystitis is a very common infection of the lower urinary tract. Women are typically affected, and more than 30 percent will experience at least one episode of cystitis in their lifetime. The diagnosis of this condition and its management are widely known and applied in the outpatient healthcare setting. However, recurrent cystitis, associated with a significant morbidity, is more challenging since their diagnostic evaluation, management and prevention differ significantly between disciplines. Several treatment and prevention options are offered to women with recurrent cystitis. Antibiotic prevention and treatment options should not be first-line, given the importance to limit resistance development and efficacy of alternatives in most situations. The proposed chapter is a narrative review on the current state-of-the-art for the diagnostic evaluation, management and prevention of recurrent cystitis, and aims to discuss other issues and aspects that could be addressed for an optimal management of this condition.
- 11 October 2023
- Published by IntechOpen
Open AccessRecurrent Cystitis in Women: Optimal Recommended Diagnostic Evaluation, Management and Prevention Options
Cystitis is a very common infection of the lower urinary tract. Women are typically affected, and more than 30 percent will experience at least one episode of cystitis in their lifetime. The diagnosis of this condition and its management are widely known and applied in the outpatient healthcare setting. However, recurrent cystitis, associated with a significant morbidity, is more challenging since their diagnostic evaluation, management and prevention differ significantly between disciplines. Several treatment and prevention options are offered to women with recurrent cystitis. Antibiotic prevention and treatment options should not be first-line, given the importance to limit resistance development and efficacy of alternatives in most situations. The proposed chapter is a narrative review on the current state-of-the-art for the diagnostic evaluation, management and prevention of recurrent cystitis, and aims to discuss other issues and aspects that could be addressed for an optimal management of this condition.
- Open Access
- 16 April 2021
- Published by African Journals Online (AJOL) in African Health Sciences
- Vol. 21 (1) , 273-6
Neurological manifestations following cured malaria: don’t forget post-malaria neurological syndrome
Introduction: Cerebral malaria which occurs during the active infection is the most common neurological complication of malaria. Other complications including post-malaria neurological syndrome (PMNS) can rarely occur following complete recovery from the disease. We report a case of post-malaria neurological syndrome in a Tunisian patient. Case presentation: A 26-year-old Tunisian man with no past medical history was admitted in 2016 for a muscle weakness of the 4 limbs, seizures, tetraparesis and myoclonus which appeared after he returned from Côte d’Ivoire where he had been treated three weeks ago for Plasmodium falciparum malaria with favorable outcome. Blood smears for malaria were negative. Brain MRI showed multiple hypersignal cerebral lesions. Investigations didn’t show any infectious, metabolic, toxic, vascular or tumoral etiology. Thus, the diagnosis of PMNS was considered. The patient was treated with methylprednisolone with favorable outcome. Two years later, he was completely asymptomatic. Conclusion: PMNS should be considered in patients with neurological symptoms occurring within two months of cured acute disease in which blood smears for malaria are negative and other etiologies have been ruled out. In most cases, the disease is self-limited while in severe cases corticosteroid therapy should be prescribed with favorable outcome. Keywords: Post-malaria neurological syndrome; immunologic; corticosteroid.
- 16 April 2021
- Published by African Journals Online (AJOL) in African Health Sciences
- Vol. 21 (1) , 273-6
Open AccessNeurological manifestations following cured malaria: don’t forget post-malaria neurological syndrome
Introduction: Cerebral malaria which occurs during the active infection is the most common neurological complication of malaria. Other complications including post-malaria neurological syndrome (PMNS) can rarely occur following complete recovery from the disease. We report a case of post-malaria neurological syndrome in a Tunisian patient. Case presentation: A 26-year-old Tunisian man with no past medical history was admitted in 2016 for a muscle weakness of the 4 limbs, seizures, tetraparesis and myoclonus which appeared after he returned from Côte d’Ivoire where he had been treated three weeks ago for Plasmodium falciparum malaria with favorable outcome. Blood smears for malaria were negative. Brain MRI showed multiple hypersignal cerebral lesions. Investigations didn’t show any infectious, metabolic, toxic, vascular or tumoral etiology. Thus, the diagnosis of PMNS was considered. The patient was treated with methylprednisolone with favorable outcome. Two years later, he was completely asymptomatic. Conclusion: PMNS should be considered in patients with neurological symptoms occurring within two months of cured acute disease in which blood smears for malaria are negative and other etiologies have been ruled out. In most cases, the disease is self-limited while in severe cases corticosteroid therapy should be prescribed with favorable outcome. Keywords: Post-malaria neurological syndrome; immunologic; corticosteroid.